Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Dementia with Lewy bodies (DLB) is a common neurodegenerative disorder in which patients exhibit symptoms of dementia and parkinsonism along with fluctuations and hallucinations that can be ...

That is, except one, which combined the drug with Aricept, a widely used drug already available on the market and used to treat Alzheimer's symptoms like memory loss and confusion. Together ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

Donepezil (Aricept) was approved in 1996, Rivastigmine (Exelon) was approved in 2000, and galantamine (Reminyl) was approved in 2001. In October, 2003, the FDA approved Memantine (Namenda) for the ...

Currently, the only treatments for Alzheimer's disease on the market ... These drugs include Pfizer's (New York) Aricept, Novartis's (Basel, Switzerland) Exelon and, most recently, Shire ...

Data from a large multicenter study demonstrate that donepezil can delay the rate of progression from mild cognitive impairment to Alzheimer disease in patients with depressive symptoms ...